⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANIX News
Anixa Biosciences, Inc.
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
prnewswire.com
ANIX
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
prnewswire.com
ANIX
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
prnewswire.com
ANIX
Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
prnewswire.com
ANIX
Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
prnewswire.com
ANIX
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
prnewswire.com
ANIX
Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
prnewswire.com
ANIX
Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034
prnewswire.com
GTBP
LXEO
ANIX
TEM
CTOR
GTBP
LXEO
ANIX
TEM
CTOR
Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
prnewswire.com
ANIX
Cleveland Clinic to Present Final Results of Phase 1 Clinical Trial for Anixa Biosciences' Breast Cancer Vaccine at 2025 San Antonio Breast Cancer Symposium
prnewswire.com
ANIX